OCS

7.0605.11%
BT

Bjorn Tackenberg

Chief Scientific Officer

Prof. Bjo¨rn Tackenberg, M.D. Ph.D. FEAN FAAN, is Chief Scientific Officer of Oculis Holding AG from November 2026. Prof. Tackenberg joined the Oculis Holding AG in November 2026. He is Professor of Neurology. Prof. Tackenberg joined Oculis from Roche, where he served as Head of Integrative Neuroscience & Medical Practice, encompassing clinical development plans and study design, biomarker development and evidence-generation strategies and strategic partnerships with academic and scientific institutions. Previously, he served as Head of the Center of Neuroimmunology and Vice-Chair of the Department of Neurology at Marburg University in Germany from 2008 to 2019. During his tenure, he established a clinical trials unit that conducted more than 75 randomized controlled trials in autoimmune indications and a tertiary reference center for complex autoimmune treatments. As an experienced and successful industry leader, board-certified neurologist and physician-scientist, Prof. Tackenberg holds deep clinical and scientific expertise in MS, neuroimmunology, neurodegenerative and neuromuscular diseases. He has authored or co-authored over 135 original publications, as well as treatment guidelines for MS, myasthenia gravis and inflammatory neuropathies. His career bridges basic neuroscience and academic clinical neurology, translational research, pharmaceutical and biomarker development and scientific and medical affairs. Prof. Tackenberg is a Fellow of both the European Academy of Neurology and the American Academy of Neurology.

Positions